[Federal Register Volume 79, Number 212 (Monday, November 3, 2014)]
[Notices]
[Pages 65221-65222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-26021]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the Joint 
meeting of the National Cancer Advisory Board (NCAB) and NCI Board of 
Scientific Advisors (BSA).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the Joint NCAB/BSA meeting will be closed to the 
public in accordance with the provisions set forth in section 
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual intramural programs and projects conducted by 
the National Cancer Institute, including consideration of personnel 
qualification and performance, and the competence of individual 
investigators, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board; ad Hoc 
Subcommittee on Global Cancer Research.
    Open: December 1, 2014, 6:00 p.m. to 7:30 p.m.
    Agenda: Discussion on Global Cancer Research.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, Maryland 20814.
    Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB ad 
Hoc Subcommittee on Global Cancer Research, National Cancer 
Institute, National Institutes of Health, 9609 Medical Center Drive, 
Room 3W-562, Bethesda, MD 20892, (240) 276-5796, 
[email protected].

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Open: December 2, 2014, 8:30 a.m. to 5:15 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board; and 
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors 
Concepts Review, NCI Director's report, and presentations.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Closed: December 2, 2014, 5:15 p.m. to 6:00 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 9606 
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit. Information is also available on the Institute's/Center's 
home page: NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, 
BSA: http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 65222]]


    Dated: October 28, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-26021 Filed 10-31-14; 8:45 am]
BILLING CODE 4140-01-P